Chronic News and Research

RSS

Study of stroke survivors shows how chronic pain can alter body perception

A world-first study of stroke survivors shows how chronic pain can alter body perception, with the brain tricking patients into believing their affected hand is a different size, increasing the risk of accidents.

12 Dec 2022

COVID vaccine hesitancy may be associated with increased risks of traffic accidents

Reasons underlying hesitancy to get vaccinated against COVID-19 may be associated with increased risks of traffic accidents according to a new study in The American Journal of Medicine, published by Elsevier. Researchers found that adults who neglect these health recommendations may also neglect basic road safety.

12 Dec 2022

Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.

12 Dec 2022

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab - a novel, patient-tailored monoclonal antibody therapy - showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia

A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remissions in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial led by Dana-Farber Cancer Institute investigators indicates.

12 Dec 2022

$Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction$

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF) >40%, including HF with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF).

From AstraZeneca 12 Dec 2022

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

For people ages 75 and older, age-related changes in general health and in the heart and blood vessels require consideration and likely modifications in how heart attacks and heart disease are treated, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

12 Dec 2022

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

Researchers from the University of Pennsylvania's Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology Annual Meeting.

12 Dec 2022

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.

12 Dec 2022

How vaping impacts alveolar macrophage lipid content

The use of e-cigs increases the risk of acute respiratory syndrome.

11 Dec 2022

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.

9 Dec 2022

How does the Mediterranean diet associate with cognitive risk and functional ability in adults?

A new study evaluated the associations between adherence to the Mediterranean diet (MedDiet), cognitive risk, and functional ability in older Australian adults.

9 Dec 2022

What is the association between farnesoid X receptor inhibition and protection against COVID-19?

Researchers assessed the association between farnesoid X receptor (FXR) inhibition and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

9 Dec 2022

What is the importance of vitamin B12 supplementation in plant-based diets?

Researchers emphasize the importance of vitamin B12 supplementation for individuals consuming a plant-based or vegan diet.

9 Dec 2022

High levels of arsenic contamination in water linked to antibiotic resistance carriage among children

In rural Bangladesh, areas with high levels of arsenic contamination in drinking water, compared to areas with less contamination, have a higher prevalence of antibiotic-resistant Escherichia coli in both water and child stool samples, according to a new study publishing December 8, 2022 in PLOS Pathogens by Mohammad Aminul Islam of Washington State University, and colleagues.

8 Dec 2022

Chronic News and Research

Study of stroke survivors shows how chronic pain can alter body perception

COVID vaccine hesitancy may be associated with increased risks of traffic accidents

Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

Ongoing Phase I clinical trial demonstrates successful re-treatment with CAR T cell therapy

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

How vaping impacts alveolar macrophage lipid content

Researchers seek to reduce Chikungunya virus-caused joint pain with new drug

How does the Mediterranean diet associate with cognitive risk and functional ability in adults?

What is the association between farnesoid X receptor inhibition and protection against COVID-19?

What is the importance of vitamin B12 supplementation in plant-based diets?

High levels of arsenic contamination in water linked to antibiotic resistance carriage among children

For patients with sickle cell disease, fertility care is about reproductive justice

Liver cancer study could help improve the safety of certain gene therapies for hemophilia

Genes related to alcohol and tobacco use are similar among people with diverse ancestries

Study: People with higher levels of vitamin D in the brain have better cognitive function

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News